Related Experiment Video
Updated: Jul 7, 2026
06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
[Gene-diet interactions in atherogenic dyslipidemias (part 2)]
Casopis Lekaru Ceskych
|February 9, 2008
Summary
Genetic variations in lipid-related genes, like fatty acid binding protein and PPARs, influence how the body responds to diet. Understanding these gene-environment interactions is key for preventing cardiovascular disease.
Area of Science:
- Biochemistry
- Genetics
- Nutritional Science
Context:
- Focuses on functional polymorphisms in lipid-related genes, including fatty acid binding protein, lipoprotein lipase, hepatic lipase, and PPARs.
- Explores the interplay between genetic variability and metabolic responses to dietary factors.
Purpose:
- To review the influence of gene polymorphisms on metabolic responses to diet.
- To highlight the bidirectional relationship between dietary habits and gene expression.
- To underscore the role of genetic predisposition and nutritional factors in atherosclerosis and cardiovascular disease.
Summary:
- Gene polymorphisms significantly affect metabolic responses to dietary interventions.
- Dietary habits can modulate the expression of specific genotypes.
- Atherosclerosis and cardiovascular disease result from combined nutritional factors and genetic predisposition.
Impact:
- Enhanced understanding of gene-gene and gene-environment interactions in cardiovascular risk.
- Potential for developing novel preventive and therapeutic strategies for cardiovascular diseases.
- Foundation for personalized nutrition and medicine approaches based on genetic profiles.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...